COLGATE-PALMOLIVE COMPANY FY 2025 10-K, explained in plain English
Key financials — as reported
| Total revenue | $20.4B |
| Gross margin | 60.1% |
| Operating income | $3.3B |
| Net income | $2.1B |
| Diluted EPS | $2.63 |
| Cash & equivalents | $1.3B |
| Total assets | $16.3B |
| Long-term debt | $7.8B |
Key takeaway
Net sales grew 1.4% to $20,382M in 2025, led by 2.1% pricing gains in both the Oral, Personal and Home Care and Hill's Pet Nutrition segments.
🔒 4 more takeaways in the full analysis
Beneath the surface
The $919M pretax goodwill/intangible impairment on the skin health business (Filorga) materially depressed operating income and net income, masking otherwise modest underlying growth.
🔒 3 more insights a headline reader would miss
This is the free preview. The full analysis explains every line item above and includes 7 more findings — plus insider trades, activist stakes, and 8-K events for CL.
Read the full analysis free Free account · 5 full analyses included · no card required